We use analytics to improve Pollar and, with your consent, the Meta pixel to measure sign-ups and purchases that come from our ads. You can change this anytime in Settings. Privacy policy

Search⌘K
HomeFor YouLiveBriefAsk
MapMarketsThreadsSoundsFilmsRadar
DomesticGeopoliticsEconomySocietyScience & TechInfrastructureSportCultureLifestyle
Support Pollar
ContactPublisher
Thomas Schinecker

Thomas Schinecker

Austrian-German pharmaceutical executive
Watch in RadarView on Wikipedia

Photo: Ministerio de la Presidencia. Gobierno de España, CC BY 3.0 (Wikimedia Commons, cropped)

Headlines and summaries are written by AI. How it works

  • 52m ago

    US regulator approves Roche's oral breast cancer pill Wilserdly for ESR1-mutated disease

    The FDA approved Roche's oral giredestrant, sold as Wilserdly, together with everolimus on Monday, 16 November. A second US decision on early-stage use is expected by late November, and Roche expects sales contributions from 2027.

  • About
  • Editorial standards
  • Corrections
  • AI policy
  • Privacy
  • Terms
  • Contact

Top stories now

  • 16:14Deutsche Bank shares fall as 15 million leaked files surface
  • 15:18Trump takes Iran dirty bomb report in Washington seriously
  • 13:57Diallo, UEFA's pick, enters the FIFA presidency race

Morning Brief 05:05

Russian strikes hit Kyiv bridges
Synthetic voice (AI)
Read the Brief
HomeBriefLiveThreadsSearch